Lobbying

Neuroflow's latest lobbying report covers Q2 2026, at $40K. The four quarters Q4 2025–Q3 2026 total $100K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Budget/Appropriations.

Neuroflow

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$100K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Neuroflow lobbying by quarter
Neuroflow lobbying by quarter
QuarterAmountReports
Q4 2022$20K1
Q1 2023$20K1
Q2 2023$20K1
Q3 2023$20K1
Q4 2023$20K1
Q1 2024$20K1
Q2 2024$20K1
Q3 2024$20K1
Q4 2024$20K1
Q1 2025$20K1
Q2 2025$20K1
Q3 2025$20K1
Q4 2025$20K1
Q1 2026$40K2
Q2 2026$40K2
Q3 2026$00

By issue

  • Health issues$300K · 15 reports
  • Budget and appropriations$40K · 2 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES17 reports
  • SENATE17 reports
  • Veterans Affairs, Dept of (VA)16 reports
  • Air Force, Dept of15 reports
  • Army, Dept of (Other)12 reports
  • Defense, Dept of (DOD)12 reports
  • Health & Human Services, Dept of (HHS)8 reports
  • U.S. Coast Guard (USCG)5 reports

Firms it paid

Firm
Nossaman$300K15 quarters
Duane Morris Government Strategies$40K2 quarters

Former officials lobbying for it

Former position
CHRISTOPHER CARNEYFormer CongressmanQ2 2026

Lobbying reports

Filed by
07/20for Q2Duane Morris Government Strategies$20K
07/20for Q2Nossaman$20K
04/20for Q1Duane Morris Government Strategies$20K
04/20for Q1Nossaman$20K
02/17for Q1Duane Morris Government StrategiesUnder $5,000
01/20for Q4 2025Nossaman$20K
25/10/20for Q3 2025Nossaman$20K
25/07/21for Q2 2025Nossaman$20K
25/04/21for Q1 2025Nossaman$20K
25/01/21for Q4 2024Nossaman$20K
24/10/21for Q3 2024Nossaman$20K
24/07/22for Q2 2024Nossaman$20K
24/04/22for Q1 2024Nossaman$20K
24/01/22for Q4 2023Nossaman$20K
23/10/20for Q3 2023Nossaman$20K
23/07/20for Q2 2023Nossaman$20K
23/04/20for Q1 2023Nossaman$20K
23/01/20for Q4 2022Nossaman$20K